Association Between Number of Endoscopic Resections and Utilization of Bacillus Calmette-Guérin Therapy for Patients With High-Grade, Non-Muscle-Invasive Bladder Cancer.

Citation data:

Clinical genitourinary cancer, ISSN: 1938-0682, Vol: 15, Issue: 1, Page: e25-e31

Publication Year:
2017
Usage 13
Abstract Views 13
Captures 18
Readers 12
Exports-Saves 6
Citations 3
Citation Indexes 3
PMID:
27432529
DOI:
10.1016/j.clgc.2016.06.014
PMCID:
PMC5183565
Author(s):
Lenis, Andrew T; Donin, Nicholas M; Litwin, Mark S; Saigal, Christopher S; Lai, Julie; Hanley, Jan M; Konety, Badrinath R; Chamie, Karim; Urologic Diseases in America Project
Publisher(s):
Elsevier BV
Tags:
Medicine
article description
Bacillus Calmette-Guérin (BCG) is the reference standard treatment for patients with high-grade, non-muscle-invasive bladder cancer (NMIBC). We previously described noncompliance with guidelines for BCG use in patients with high-risk disease. In the current study, we sought to characterize how the number of endoscopic resections of bladder tumors affects BCG utilization using population-level data.